Vital Therapies Announces First Quarter 2017 Financial Results
09. Mai 2017 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, May 09, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates
04. Mai 2017 07:45 ET
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...